Application of Artificial Intelligence in Paediatric Neurology: Narrative Review

Bachir Abdul Jawad Farzat¹, Abdul Razaq Yousefi^2*, Nadia Shaukat Ali Nisar³,  Mohamed Bachir Farzat⁴

1. Syrian BOARD general pediatric, Specialist Senior Paediatrician emergency medicine Al Jalila Children's Specialty Hospital, Dubai.

2. Diploma in Child Health (DCH), MRCPCH UK. Specialist Senior Paediatrician.

Al Jalila Children's Specialty Hospital. Dubai

3. MBChB, PGPN, Dip Diabetes, Master of Clinical Paediatrics, PhD Clinical Paediatrics, FRCPCH, Specialist Senior Paediatrician, Al Jalila Children's Specialty Hospital, Dubai.

4. Doctor of medicine. Masaryk University

*Correspondence to:  Abdul Razaq Yousefi, Diploma in Child Health (DCH), MRCPCH UK. Specialist Senior Paediatrician.

Copyright

© 2025: Abdul Razaq Yousefi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 30 Dec 2024

Published: 17 Jan 2025

Abstract

Introduction: Pediatric neurology is a complex field with a diverse range of neurological disorders affecting children. Artificial intelligence (AI) has emerged as a promising tool to address the challenges in diagnosing and managing these conditions.

Aims: This narrative review aims to explore the current applications of AI in pediatric neurology, assess its potential benefits, and identify future directions for research and clinical practice.

Methodology: A comprehensive literature search was conducted using PubMed, Scopus, and Google Scholar to identify relevant studies published in English. The included studies were systematically reviewed to extract key information on the application of AI in pediatric neurology.

Results: AI has shown significant potential in various areas of pediatric neurology, including medical image analysis, natural language processing, decision support systems, and predictive modelling. AI-powered tools can improve diagnostic accuracy, enhance treatment planning, and facilitate early intervention.

Conclusion: AI has the potential to revolutionize pediatric neurology. However, challenges such as data quality, algorithmic bias, and ethical considerations need to be addressed to ensure the safe and effective implementation of AI in clinical practice. Future research should focus on developing robust and interpretable AI models, addressing ethical concerns, and integrating AI into clinical workflows.

Keywords: artificial intelligence, pediatric neurology, medical imaging, natural language processing, decision support systems, predictive modelling

Introduction

Pediatric neurology, a complex and rapidly evolving field, presents unique challenges in diagnosing and managing a diverse range of neurological disorders in children. (1) The increasing complexity of these conditions, coupled with the ever-growing volume of medical data, necessitates innovative approaches to improve diagnostic accuracy, treatment efficacy, and patient outcomes. Artificial intelligence (AI), with its potential to analyze vast amounts of data and identify intricate patterns, has emerged as a promising tool to revolutionize pediatric neurology. (2)                                                         

AI, a broad field encompassing various techniques such as machine learning, deep learning, and natural language processing, has the potential to transform numerous aspects of pediatric neurological care.   By leveraging AI algorithms, clinicians can enhance the accuracy and efficiency of diagnostic processes, personalize treatment plans, and improve prognostication. (3)

One of the most significant applications of AI in pediatric neurology lies in the field of medical imaging. AI-powered algorithms can analyze medical images, such as magnetic resonance imaging (MRI) and electroencephalography (EEG), to identify subtle abnormalities that may be missed by human observers.(4) AI can assist in the early detection of developmental disorders like autism spectrum disorder (ASD) by analyzing structural and functional brain changes. (5) Additionally, AI can help in the diagnosis of epilepsy by accurately identifying seizure patterns in EEG recordings. (6)   Another promising application of AI is in the development of decision support systems. These systems can provide clinicians with evidence-based recommendations by analyzing patient data, medical literature, and clinical guidelines. This can aid in making informed decisions about diagnostic tests, treatment options, and patient management strategies. (7)  

Furthermore, AI can be used to develop personalized treatment plans. By analyzing a patient's genetic makeup, medical history, and clinical data, AI algorithms can identify the most effective treatment strategies for individual patients. This can lead to improved treatment outcomes and reduced adverse effects. (8)  

While the potential benefits of AI in pediatric neurology are substantial, it is crucial to acknowledge the challenges and limitations associated with its implementation. Ethical considerations, such as data privacy and algorithmic bias, must be carefully addressed to ensure the responsible and equitable use of AI in clinical practice. Additionally, rigorous validation and testing of AI algorithms are necessary to establish their reliability and accuracy.  

In conclusion, AI has the potential to significantly advance the field of pediatric neurology. By leveraging its capabilities in medical imaging, decision support, and personalized medicine, AI can improve the accuracy of diagnoses, optimize treatment plans, and enhance patient outcomes. However, it is essential to approach the integration of AI with caution, addressing ethical concerns and ensuring rigorous validation to maximize its benefits while minimizing potential risks.  

 

Aims & Objectives

This narrative review aims to explore the potential of artificial intelligence (AI) in revolutionizing pediatric neurology. The objectives of this review are to: (1) systematically assess the current state-of-the-art AI applications in pediatric neurology, including medical imaging analysis, natural language processing, and decision support systems; (2) evaluate the potential benefits of AI in improving diagnostic accuracy, treatment efficacy, and patient outcomes; (3) critically analyze the challenges and limitations associated with AI implementation in clinical practice, such as data quality, algorithmic bias, and ethical considerations; and (4) discuss the future directions and research priorities for advancing AI in pediatric neurology, including the need for robust validation studies, interdisciplinary collaboration, and ethical guidelines.

 

Methodology

This narrative review was conducted to explore the potential of artificial intelligence (AI) in revolutionizing pediatric neurology. A comprehensive literature search was performed using PubMed, Scopus, and Google Scholar databases. The search terms employed included "artificial intelligence," "machine learning," "deep learning," "pediatric neurology," "medical imaging," "natural language processing," and "decision support systems."

The inclusion criteria for studies were: (1) original research articles, review articles, and case reports; (2) studies focusing on the application of AI in pediatric neurology; and (3) studies published in English. Exclusion criteria included studies not directly related to pediatric neurology, those without a clear AI component, and those not published in peer-reviewed journals.

The identified studies were meticulously screened, and relevant data were extracted, including study design, sample size, AI techniques employed, performance metrics, and clinical implications. A qualitative synthesis of the extracted data was performed to identify emerging trends, challenges, and opportunities in the field.

 

Results

Applications of AI in Pediatric Neurology: Table 1 summarizes different types of AI Applications in Pediatric Neurology

Table 1: Summary of AI Applications in Pediatric Neurology
Application Area	AI Technique	Key Benefits	Challenges
Medical Imaging	CNNs, Deep Learning	Improved diagnostic accuracy, early detection of disorders	Data quality and variability, model interpretability (9)
Natural Language Processing	NLP, Machine Learning	Extraction of valuable insights from clinical notes, risk factor identification	Data quality, inconsistency, and privacy concerns (10)
Decision Support Systems	Machine Learning, AI	Personalized treatment recommendations, improved clinical decision-making	Data quality, model bias, and ethical considerations (11)
Predictive Modeling	Machine Learning, Statistical Modeling	Prediction of disease progression, risk stratification	Data quality, model complexity, and interpretability (12)
Drug Discovery and Development	AI, Machine Learning	Accelerated drug discovery, improved drug design	Data quality, computational resources, and regulatory challenges (13)

 

Table 2 describes different types of AI Applications in Pediatric Neurology by Disorder.

Table 2: AI Applications in Pediatric Neurology by Disorder
Disorder	Key Applications
Autism Spectrum Disorder (ASD)	Early diagnosis, phenotype characterization (14)
Attention-Deficit/Hyperactivity Disorder (ADHD)	Early diagnosis, treatment response prediction (15)
Epilepsy	Seizure detection, prediction, and classification (16)
Cerebral Palsy	Gait analysis, motor function assessment (17)
Neurodegenerative Diseases	Early diagnosis, disease progression monitoring (18)

 

Medical Imaging Analysis:

Brain Tumor Detection and Classification:

Convolutional Neural Networks (CNNs): CNNs have been effectively employed to automatically detect and classify brain tumors in pediatric patients with high accuracy. These models can analyze MRI and CT images to identify tumor characteristics such as size, location, malignancy grade, and potential infiltration into surrounding tissues. (19)

Radiomics: By extracting quantitative features from medical images, radiomics can aid in the early detection and accurate classification of brain tumors. AI-powered radiomic analysis can improve the sensitivity and specificity of tumor diagnosis, especially in cases with subtle or atypical appearances. (20)

Segmentation and Tracking: AI-powered segmentation techniques can accurately delineate tumor boundaries, facilitating surgical planning and radiation therapy. Additionally, AI-driven tracking algorithms can monitor tumor growth and response to treatment over time. (21)

Neurodevelopmental Disorder Diagnosis:

Autism Spectrum Disorder (ASD): AI algorithms, particularly deep learning models, have been used to analyze structural and functional brain abnormalities in children with ASD. By examining MRI and functional MRI (fMRI) data, these models can identify subtle patterns associated with ASD, such as altered brain connectivity and reduced cortical thickness, leading to earlier and more accurate diagnosis. (22)

Attention Deficit Hyperactivity Disorder (ADHD): AI-powered analysis of neuroimaging data, such as diffusion tensor imaging (DTI), can help identify structural and functional brain differences in children with ADHD. This can aid in the differential diagnosis of ADHD from other neurodevelopmental disorders and inform personalized treatment strategies. (23)

 

Epilepsy Diagnosis and Seizure Prediction:

Electroencephalography (EEG): AI algorithms can analyze EEG recordings to automatically detect and classify different types of seizures, including focal seizures, generalized seizures, and absence seizures. This can help in the accurate diagnosis of epilepsy and the optimization of treatment plans. (24)

Seizure Prediction: AI-powered models can analyze patient data, including EEG recordings, clinical information, and wearable device data, to predict the onset of seizures. This can enable early intervention, such as medication administration or environmental adjustments, to reduce the frequency and severity of seizures. (25)

 

Natural Language Processing

Medical Record Analysis:

Phenotype Extraction: NLP techniques can extract relevant phenotypic information from clinical notes, such as patient demographics, medical history, treatment outcomes, and genetic mutations. This information can be used to identify patients with rare genetic disorders, facilitate genetic counseling, and inform clinical decision-making. (26)

Risk Factor Identification: By analyzing large volumes of clinical text, NLP can identify risk factors for various neurological conditions, including genetic mutations, environmental exposures, and lifestyle factors. (27)

Clinical Decision Support: NLP can be used to generate clinical decision support systems that provide evidence-based recommendations to clinicians. For example, NLP can analyze clinical guidelines and medical literature to provide information on best practices for specific neurological conditions. (28)

 

Decision Support Systems

Treatment Recommendation:

Personalized Medicine: AI-powered decision support systems can analyze patient-specific data, such as genetic information, medical history, and clinical findings, to recommend personalized treatment plans. This can help optimize treatment outcomes and minimize adverse effects. (29)

Drug Prescription: AI algorithms can assist in the selection of appropriate medications by considering factors such as drug interactions, patient comorbidities, and treatment guidelines. (30)

Surgical Planning: AI can aid in surgical planning by analyzing preoperative imaging data to identify optimal surgical approaches and predict potential complications. (31)

Predictive Modeling

Disease Progression: AI models can predict the progression of neurological disorders, such as neurodegenerative diseases, by analyzing clinical data, genetic information, and imaging biomarkers. This can help in early intervention and disease management. (32)

Patient Outcome Prediction: AI can predict patient outcomes, such as mortality and functional impairment, based on a variety of factors, including demographic information, medical history, and treatment response. This can aid in risk stratification and resource allocation. (33)

Drug Discovery and Development

AI is being used to accelerate the discovery and development of new drugs for pediatric neurological disorders. By analyzing vast amounts of biological data, AI can identify potential drug targets, predict drug efficacy and toxicity, and optimize drug design. This can lead to the development of more effective and safer treatments for pediatric neurological conditions. (34)

Additionally, AI can be used to develop wearable devices and mobile applications that can monitor patient health, track symptoms, and provide real-time feedback. These technologies can improve patient engagement, adherence to treatment plans, and overall quality of life.

 

Discussion

The integration of artificial intelligence (AI) into pediatric neurology has the potential to revolutionize the field, offering significant advancements in diagnosis, treatment, and patient care. This narrative review has explored the diverse applications of AI in pediatric neurology, including medical imaging analysis, natural language processing, decision support systems, and predictive modelling.

AI-powered analysis of medical images has significantly improved the accuracy and efficiency of diagnosing various neurological disorders in children. Deep learning algorithms, particularly convolutional neural networks (CNNs), have been instrumental in detecting and classifying brain tumors, identifying subtle abnormalities associated with neurodevelopmental disorders like ASD, and detecting seizure patterns in EEG recordings. These advances have the potential to lead to earlier diagnosis, more accurate prognosis, and improved treatment outcomes. (35)

However, challenges remain in ensuring the reliability and generalizability of AI-based image analysis models. Factors such as variability in image quality, patient demographics, and disease subtypes can impact the performance of these models. (36) Future research should focus on developing robust and adaptable AI algorithms that can accurately analyze diverse datasets and provide reliable clinical insights.

Natural language processing (NLP) techniques have the potential to unlock valuable insights from large volumes of unstructured clinical text. By analyzing electronic health records (EHRs) and clinical notes, NLP can identify relevant information, such as patient demographics, medical history, and treatment outcomes. (37) This information can be used to identify patients at risk for specific neurological conditions, predict disease progression, and personalize treatment plans. However, NLP models are heavily reliant on the quality and quantity of training data. To improve the accuracy and reliability of NLP-based applications, it is crucial to develop robust data curation and annotation processes. (38)

AI-powered decision support systems can provide clinicians with evidence-based recommendations to improve patient care. By analyzing large datasets, including clinical guidelines, medical literature, and patient-specific information, these systems can generate personalized treatment plans. However, the effectiveness of these systems depends on the quality of the underlying data and the accuracy of the AI algorithms. It is essential to ensure that AI-based decision support systems are transparent, explainable, and aligned with clinical guidelines. (39)  

AI-based predictive models can forecast disease progression and identify patients at high risk of adverse outcomes. By analyzing a variety of factors, including genetic information, clinical data, and environmental exposures, these models can help clinicians make proactive interventions to prevent disease progression and improve patient outcomes. (40) However, the accuracy of predictive models depends on the quality of the input data and the robustness of the underlying algorithms. It is important to validate these models in large, diverse patient populations to ensure their clinical utility. (41)

AI is accelerating the discovery and development of new drugs for pediatric neurological disorders. By analyzing vast amounts of biological data, AI can identify potential drug targets, predict drug efficacy and toxicity, and optimize drug design. (42) This can lead to the development of more effective and safer treatments for pediatric neurological conditions. However, challenges remain in translating AI-driven drug discovery into clinical applications. Rigorous clinical trials are essential to validate the safety and efficacy of AI-identified drug candidates.

As AI becomes increasingly integrated into pediatric neurology, it is crucial to address ethical considerations, including data privacy, algorithmic bias, and transparency. It is essential to ensure that AI systems are developed and deployed in an ethical and responsible manner.

 

Future Research Points

Future research should focus on several key areas. Continued development of advanced AI techniques, such as deep learning and reinforcement learning, can further enhance the accuracy and efficiency of AI applications. The establishment of large-scale, well-annotated datasets can facilitate the development and training of robust AI models. Addressing ethical considerations and developing regulatory frameworks is crucial to ensure the responsible and equitable use of AI in healthcare. Fostering interdisciplinary collaboration between neurologists, computer scientists, engineers, and ethicists can accelerate the development and implementation of AI-based solutions. AI systems should be designed with the needs and preferences of clinicians and patients in mind to ensure user acceptance and optimal performance. Developing AI models that can provide clear and interpretable explanations for their decisions can enhance trust and facilitate clinical adoption. Leveraging AI to develop personalized treatment plans based on individual patient characteristics can improve treatment outcomes. Finally, AI-powered devices and applications can enable remote monitoring of patients, facilitating early intervention and improving access to care.

 

Study Limitations

While this narrative review provides a comprehensive overview of the potential applications of AI in pediatric neurology, several limitations should be acknowledged. The quality and quantity of available data can significantly impact the performance of AI models, and data privacy and ethical considerations may limit data sharing and access. Many AI models, particularly deep learning models, are considered "black box" models, making it difficult to understand the underlying decision-making process. This lack of interpretability can hinder clinical trust and adoption. The generalizability of findings from AI studies may be limited by factors such as patient populations, data quality, and model architectures. It is important to validate AI models in diverse clinical settings to ensure their reliability and effectiveness. The ethical implications of using AI in healthcare, including issues of bias, fairness, and accountability, need to be carefully considered. Ensuring transparency and responsible AI development is crucial to build trust and mitigate potential risks. Addressing these limitations will be essential to fully realize the potential of AI in pediatric neurology.

 

Conclusion

AI has the potential to revolutionize pediatric neurology. By leveraging the power of AI, we can improve diagnostic accuracy, optimize treatment plans, and enhance patient outcomes. However, it is essential to address the challenges and limitations associated with AI, including data quality, algorithmic bias, and interpretability. By carefully considering these factors, we can harness the full potential of AI to improve the lives of children with neurological disorders.

 

References

1. Bonkowsky JL, deVeber G, Kosofsky BE; Child Neurology Society Research Committee. Pediatric Neurology Research in the Twenty-First Century: Status, Challenges, and Future Directions Post-COVID-19. Pediatr Neurol. 2020 Dec; 113:2-12. doi: 10.1016/j.pediatrneurol.2020.08.012. Epub 2020 Aug 26. PMID: 32979654; PMCID: PMC10256134.

2.  Bajwa J, Munir U, Nori A, Williams B. Artificial intelligence in healthcare: transforming the practice of medicine. Future Healthc J. 2021 Jul;8(2):e188-e194. doi: 10.7861/fhj.2021-0095. PMID: 34286183; PMCID: PMC8285156.

3.  Maleki Varnosfaderani S, Forouzanfar M. The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century. Bioengineering (Basel). 2024 Mar 29;11(4):337. doi: 10.3390/bioengineering11040337. PMID: 38671759; PMCID: PMC11047988.

4. Pinto-Coelho L. How Artificial Intelligence Is Shaping Medical Imaging Technology: A Survey of Innovations and Applications. Bioengineering (Basel). 2023 Dec 18;10(12):1435. doi: 10.3390/bioengineering10121435. PMID: 38136026; PMCID: PMC10740686.

5. Song DY, Kim SY, Bong G, Kim JM, Yoo HJ. The Use of Artificial Intelligence in Screening and Diagnosis of Autism Spectrum Disorder: A Literature Review. Soa Chongsonyon Chongsin Uihak. 2019 Oct 1;30(4):145-152. doi: 10.5765/jkacap.190027. PMID: 32595335; PMCID: PMC7298904.

6. Chung YG, Jeon Y, Yoo S, Kim H, Hwang H. Big data analysis and artificial intelligence in epilepsy - common data model analysis and machine learning-based seizure detection and forecasting. Clin Exp Pediatr. 2022 Jun;65(6):272-282. doi: 10.3345/cep.2021.00766. Epub 2021 Nov 26. PMID: 34844397; PMCID: PMC9171464.

7. Khosravi M, Zare Z, Mojtabaeian SM, Izadi R. Artificial Intelligence and Decision-Making in Healthcare: A Thematic Analysis of a Systematic Review of Reviews. Health Serv Res Manag Epidemiol. 2024 Mar 5;11:23333928241234863. doi: 10.1177/23333928241234863. PMID: 38449840; PMCID: PMC10916499.

8. Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, Zhao J, Snowdon JL. Precision Medicine, AI, and the Future of Personalized Health Care. Clin Transl Sci. 2021 Jan;14(1):86-93. doi: 10.1111/cts.12884. Epub 2020 Oct 12. PMID: 32961010; PMCID: PMC7877825.

9. Thakur GK, Thakur A, Kulkarni S, Khan N, Khan S. Deep Learning Approaches for Medical Image Analysis and Diagnosis. Cureus. 2024 May 2;16(5):e59507. doi: 10.7759/cureus.59507. PMID: 38826977; PMCID: PMC11144045.

10. Sheikhalishahi S, Miotto R, Dudley JT, Lavelli A, Rinaldi F, Osmani V. Natural Language Processing of Clinical Notes on Chronic Diseases: Systematic Review. JMIR Med Inform. 2019 Apr 27;7(2):e12239. doi: 10.2196/12239. PMID: 31066697; PMCID: PMC6528438.

11. Elhaddad M, Hamam S. AI-Driven Clinical Decision Support Systems: An Ongoing Pursuit of Potential. Cureus. 2024 Apr 6;16(4):e57728. doi: 10.7759/cureus.57728. PMID: 38711724; PMCID: PMC11073764.

12. Toma, M.; Wei, O.C. Predictive Modeling in Medicine. Encyclopedia 2023, 3, 590-601. https://doi.org/10.3390/encyclopedia3020042

13. Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021 Jan;26(1):80-93. doi: 10.1016/j.drudis.2020.10.010. Epub 2020 Oct 21. PMID: 33099022; PMCID: PMC7577280.

14.  Moridian P, Ghassemi N, Jafari M, Salloum-Asfar S, Sadeghi D, Khodatars M, Shoeibi A, Khosravi A, Ling SH, Subasi A, Alizadehsani R, Gorriz JM, Abdulla SA, Acharya UR. Automatic autism spectrum disorder detection using artificial intelligence methods with MRI neuroimaging: A review. Front Mol Neurosci. 2022 Oct 4;15:999605. doi: 10.3389/fnmol.2022.999605. PMID: 36267703; PMCID: PMC9577321.

15.  Cao, M., Martin, E. & Li, X. Machine learning in attention-deficit/hyperactivity disorder: new approaches toward understanding the neural mechanisms. Transl Psychiatry 13, 236 (2023). https://doi.org/10.1038/s41398-023-02536-w

16.  Cendes F, McDonald CR. Artificial Intelligence Applications in the Imaging of Epilepsy and Its Comorbidities: Present and Future. Epilepsy Curr. 2022 Jan 12;22(2):91-96. doi: 10.1177/15357597211068600. PMID: 35444507; PMCID: PMC8988724.

17.  Duran I, Stark C, Saglam A, Semmelweis A, Lioba Wunram H, Spiess K, Schoenau E. Artificial intelligence to improve efficiency of administration of gross motor function assessment in children with cerebral palsy. Dev Med Child Neurol. 2022 Feb;64(2):228-234. doi: 10.1111/dmcn.15010. Epub 2021 Aug 13. PMID: 34387869.

18.  Kalani M, Anjankar A. Revolutionizing Neurology: The Role of Artificial Intelligence in Advancing Diagnosis and Treatment. Cureus. 2024 Jun 5;16(6):e61706. doi: 10.7759/cureus.61706. PMID: 38975469; PMCID: PMC11224934.

19.  ZainEldin H, Gamel SA, El-Kenawy EM, Alharbi AH, Khafaga DS, Ibrahim A, Talaat FM. Brain Tumor Detection and Classification Using Deep Learning and Sine-Cosine Fitness Grey Wolf Optimization. Bioengineering (Basel). 2022 Dec 22;10(1):18. doi: 10.3390/bioengineering10010018. PMID: 36671591; PMCID: PMC9854739.

20.  Tabassum M, Suman AA, Suero Molina E, Pan E, Di Ieva A, Liu S. Radiomics and Machine Learning in Brain Tumors and Their Habitat: A Systematic Review. Cancers (Basel). 2023 Jul 28;15(15):3845. doi: 10.3390/cancers15153845. PMID: 37568660; PMCID: PMC10417709.

21.  Salari E, Wang J, Wynne JF, Chang CW, Wu Y, Yang X. Artificial intelligence-based motion tracking in cancer radiotherapy: A review. J Appl Clin Med Phys. 2024 Nov;25(11):e14500. doi: 10.1002/acm2.14500. Epub 2024 Aug 28. PMID: 39194360; PMCID: PMC11540048.

22.  Alves, C.L., Toutain, T.G.L.d.O., de Carvalho Aguiar, P. et al. Diagnosis of autism spectrum disorder based on functional brain networks and machine learning. Sci Rep 13, 8072 (2023). https://doi.org/10.1038/s41598-023-34650-6

23.  Öztekin I, Garic D, Bayat M, Hernandez ML, Finlayson MA, Graziano PA, Dick AS. Structural and diffusion-weighted brain imaging predictors of attention-deficit/hyperactivity disorder and its symptomology in very young (4- to 7-year-old) children. Eur J Neurosci. 2022 Dec;56(12):6239-6257. doi: 10.1111/ejn.15842. Epub 2022 Nov 1. PMID: 36215144; PMCID: PMC10165616.

24.  Statsenko Y, Babushkin V, Talako T, Kurbatova T, Smetanina D, Simiyu GL, Habuza T, Ismail F, Almansoori TM, Gorkom KN, Szólics M, Hassan A, Ljubisavljevic M. Automatic Detection and Classification of Epileptic Seizures from EEG Data: Finding Optimal Acquisition Settings and Testing Interpretable Machine Learning Approach. Biomedicines. 2023 Aug 24;11(9):2370. doi: 10.3390/biomedicines11092370. PMID: 37760815; PMCID: PMC10525492.

25.  Kerr WT, McFarlane KN, Figueiredo Pucci G. The present and future of seizure detection, prediction, and forecasting with machine learning, including the future impact on clinical trials. Front Neurol. 2024 Jul 11;15:1425490. doi: 10.3389/fneur.2024.1425490. PMID: 39055320; PMCID: PMC11269262.

26.  Robinson JR, Wei WQ, Roden DM, Denny JC. Defining Phenotypes from Clinical Data to Drive Genomic Research. Annu Rev Biomed Data Sci. 2018 Jul;1:69-92. doi: 10.1146/annurev-biodatasci-080917-013335. Epub 2018 Apr 25. PMID: 34109303; PMCID: PMC8186527.

27.  Trinh VQ, Zhang S, Kovoor J, Gupta A, Chan WO, Gilbert T, Bacchi S. The use of natural language processing in detecting and predicting falls within the healthcare setting: a systematic review. Int J Qual Health Care. 2023 Oct 17;35(4):mzad077. doi: 10.1093/intqhc/mzad077. PMID: 37758209; PMCID: PMC10585351.

28.  Demner-Fushman D, Chapman WW, McDonald CJ. What can natural language processing do for clinical decision support? J Biomed Inform. 2009 Oct;42(5):760-72. doi: 10.1016/j.jbi.2009.08.007. Epub 2009 Aug 13. PMID: 19683066; PMCID: PMC2757540.

29.  Babel A, Taneja R, Mondello Malvestiti F, Monaco A, Donde S. Artificial Intelligence Solutions to Increase Medication Adherence in Patients With Non-communicable Diseases. Front Digit Health. 2021 Jun 29;3:669869. doi: 10.3389/fdgth.2021.669869. PMID: 34713142; PMCID: PMC8521858.

30.  Takeuchi M, Kitagawa Y. Artificial intelligence and surgery. Ann Gastroenterol Surg. 2023 Dec 18;8(1):4-5. doi: 10.1002/ags3.12766. PMID: 38250693; PMCID: PMC10797843.

31.  Oxtoby NP. Data-Driven Disease Progression Modeling. 2023 Jul 23. In: Colliot O, editor. Machine Learning for Brain Disorders [Internet]. New York, NY: Humana; 2023. Chapter 17. Available from: https://www.ncbi.nlm.nih.gov/books/NBK597485/ doi: 10.1007/978-1-0716-3195-9_17

32.  Choudhury A, Asan O. Role of Artificial Intelligence in Patient Safety Outcomes: Systematic Literature Review. JMIR Med Inform. 2020 Jul 24;8(7):e18599. doi: 10.2196/18599. PMID: 32706688; PMCID: PMC7414411.

33.  Niazi SK. The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives. Drug Des Devel Ther. 2023 Sep 6;17:2691-2725. doi: 10.2147/DDDT.S424991. PMID: 37701048; PMCID: PMC10493153.

34.  Ariana M. Familiar, Neda Khalili, Nastaran Khalili, Cassidy Schuman, Evan Grove, Karthik Viswanathan, Jakob Seidlitz, Aaron Alexander-Bloch, Anna Zapaishchykova, Benjamin H. Kann, Arastoo Vossough, Phillip B. Storm, Adam C. Resnick, Anahita Fathi Kazerooni and Ali Nabavizadeh

35. American Journal of Neuroradiology November 2024, ajnr.A8581; DOI: https://doi.org/10.3174/ajnr.A8581

36.  Panayides AS, Amini A, Filipovic ND, Sharma A, Tsaftaris SA, Young A, Foran D, Do N, Golemati S, Kurc T, Huang K, Nikita KS, Veasey BP, Zervakis M, Saltz JH, Pattichis CS. AI in Medical Imaging Informatics: Current Challenges and Future Directions. IEEE J Biomed Health Inform. 2020 Jul;24(7):1837-1857. doi: 10.1109/JBHI.2020.2991043. PMID: 32609615; PMCID: PMC8580417.

37.  Yvonne Wieland-Jorna, Daan van Kooten, Robert A Verheij, Yvonne de Man, Anneke L Francke, Mariska G Oosterveld-Vlug, Natural language processing systems for extracting information from electronic health records about activities of daily living. A systematic review, JAMIA Open, Volume 7, Issue 2, July 2024, ooae044, https://doi.org/10.1093/jamiaopen/ooae044

38.  Ghaffar Nia N, Kaplanoglu E, Nasab A. Evaluation of artificial intelligence techniques in disease diagnosis and prediction. Discov Artif Intell. 2023;3(1):5. doi: 10.1007/s44163-023-00049-5. Epub 2023 Jan 30. PMCID: PMC9885935.

39.  Alowais, S.A., Alghamdi, S.S., Alsuhebany, N. et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med Educ 23, 689 (2023). https://doi.org/10.1186/s12909-023-04698-z

40.  Dixon D, Sattar H, Moros N, Kesireddy SR, Ahsan H, Lakkimsetti M, Fatima M, Doshi D, Sadhu K, Junaid Hassan M. Unveiling the Influence of AI Predictive Analytics on Patient Outcomes: A Comprehensive Narrative Review. Cureus. 2024 May 9;16(5):e59954. doi: 10.7759/cureus.59954. PMID: 38854327; PMCID: PMC11161909.

41.  de Hond, A.A.H., Leeuwenberg, A.M., Hooft, L. et al. Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review. npj Digit. Med. 5, 2 (2022). https://doi.org/10.1038/s41746-021-00549-7

42.  Vatansever S, Schlessinger A, Wacker D, Kaniskan HÜ, Jin J, Zhou MM, Zhang B. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions. Med Res Rev. 2021 May;41(3):1427-1473. doi: 10.1002/med.21764. Epub 2020 Dec 9. PMID: 33295676; PMCID: PMC8043990.